Detalles de la búsqueda
1.
Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score-matched analysis.
Hematol Oncol
; 42(2): e3260, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38415873
2.
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis.
Ann Hematol
; 102(9): 2301-2308, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37266671
3.
A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia.
Support Care Cancer
; 30(8): 7031-7038, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35585204
4.
Significance of initial, interim and end-of-therapy 18F-FDG PET/CT for predicting transformation risk in follicular lymphoma.
Cancer Cell Int
; 21(1): 394, 2021 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34311728
5.
The value of a new prognostic model developed by lymphocyte-monocyte ratio and platelet-monocyte ratio in peripheral T-cell lymphoma.
Cancer Cell Int
; 21(1): 573, 2021 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715862
6.
Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study.
BMC Infect Dis
; 21(1): 723, 2021 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34332526
7.
Body mass index at diagnosis is associated with survival outcome in peripheral T-cell lymphoma: a study of Chinese population.
Jpn J Clin Oncol
; 50(2): 169-174, 2020 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31612913
8.
A megakaryocyte morphological classification-based predictive model for steroid sensitivity in primary immune thrombocytopenia.
Platelets
; 31(7): 939-944, 2020 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31875757
9.
Linezolid is safe on platelet count for AML patients during myelosuppression after consolidation chemotherapy.
J Clin Pharm Ther
; 45(4): 755-758, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32403181
10.
[Expression of WT1 gene and its prognostic value in patients with acute myeloid leukemia].
Zhejiang Da Xue Xue Bao Yi Xue Ban
; 48(1): 50-57, 2019 05 25.
Artículo
en Zh
| MEDLINE | ID: mdl-31102358
11.
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial.
Am J Hematol
; 98(5): E106-E109, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36789563
12.
MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells.
Acta Pharmacol Sin
; 39(12): 1894-1901, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30297804
13.
[Roles of CCAAT enhancer binding protein α in acute myeloblastic leukemia].
Zhejiang Da Xue Xue Bao Yi Xue Ban
; 47(5): 552-557, 2018 05 25.
Artículo
en Zh
| MEDLINE | ID: mdl-30693699
14.
T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT.
Blood
; 124(17): 2735-43, 2014 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25214441
15.
[Aberrant DNA methylation and its targeted therapy in acute myeloid leukemia].
Zhejiang Da Xue Xue Bao Yi Xue Ban
; 45(4): 387-394, 2016 05 25.
Artículo
en Zh
| MEDLINE | ID: mdl-27868412
16.
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Br J Haematol
; 189(6): e231-e234, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32314800
17.
Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
Ann Hematol
; 94(11): 1829-37, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26294332
18.
[A clinical observation of treatment of peripheral T-cell lymphoma with L-asparaginase-containing combination chemotherapy].
Zhonghua Nei Ke Za Zhi
; 54(2): 111-7, 2015 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-25907840
19.
[Apoptosis of acute myeloid leukemia HL-60 cells induced by CDK inhibitor SNS-032 and its molecular mechanisms].
Zhejiang Da Xue Xue Bao Yi Xue Ban
; 44(2): 174-8, 2015 03.
Artículo
en Zh
| MEDLINE | ID: mdl-26038136
20.
First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Blood
; 117(19): 5257-60, 2011 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-21403128